Patterns of Local-Regional Failure after IMRT or Passive Scattering PT with Concurrent Chemotherapy for NSCLC.
08/08/2018
/
Publications
/
IMPT
Published in the Red Journal, this retrospective analysis by MD Anderson group reviewed 212 patients treated with IMRT and PT, most (152 [72%]) had no failure...
Advanced radiation techniques for locally advanced NSCLC: IMRT and proton therapy.
08/08/2018
/
Publications
/
IMPT
IMRT
This review article examined clinical outcomes data of IMRT and PBT for locally advanced NSCLC. This review pointed out that PBT is not considered the standard...
Reirradiation for locoregionally recurrent non-small cell lung cancer.
08/08/2018
/
Publications
/
Reirradiation
IMPT
Survival
In the context of definitive retreatment, increasing reRT dose can potentially improve OS and offer a chance of cure, particularly in patients with limited loco...
Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?
04/04/2018
/
Publications
/
Dosimetry
A review by the MD Anderson group examined the available data with regard to proton therapy for thoracic malignancies, and presented the unique challenges in...
Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma (EC).
11/06/2017
/
Publications
/
IMPT
Chemotherapy
Toxicity
19 patients with EC treated with IMPT concurrently with chemotherapy. Clinical complete response was achieved in 84%.
The most common grade 3 acute toxicities...
Establishing evidence-based indications for proton therapy.
10/11/2016
/
Publications
/
Clinical Trial
PT101
An overview of current clinical trials of proton therapy published in the Red Journal. A total 122 ongoing trials with target enrolment of over 42,000 patients...
Long-term outcome of a prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer.
01/01/2017
/
Publications
This MD Anderson study published in the Green Journal reported proton therapy for early stage NSCLC patients who were not suitable for SBRT due to lesion size...
PRONTOX – a randomized control trial.
10/11/2016
/
Publications
/
Chemotherapy
Although radiochemotherapy with photons is the standard treatment for now for locally advanced NSCLC, but acute radiation-induced toxicity such as esophagitis...
NTCP Models for Severe Radiation Induced Dermatitis After IMRT or PT for Thoracic Cancer Patients.
04/03/2020
/
Publications
/
IMRT
In order to analyze the incidence of acute radiation induced dermatitis (RD) and develop normal tissue complication probability (NTCP) models for severe RD in...
Joint Estimation of Cardiac Toxicity and Recurrence Risks after Comprehensive Nodal Photon vs. PT for Breast Cancer.
12/12/2016
/
Publications
/
Toxicity
Published in the Red Journal, this study generated proton plans for 41 left-side breast cancer patients who underwent postlumpectomy comprehensive nodal photon...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.